Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoter
- 31 March 2004
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 92 (3) , 896-904
- https://doi.org/10.1016/j.ygyno.2003.12.024
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductaseOncogene, 2003
- Ovarian cancerSeminars in Oncology Nursing, 2002
- Identification of Tissue- and Cancer-Selective Promoters for the Introduction of Genes into Human Ovarian Cancer CellsGynecologic Oncology, 2002
- Second-line and subsequent therapy for ovarian carcinoma.Current Oncology Reports, 2002
- Future directions in the treatment of ovarian cancerSeminars in Oncology, 2002
- Clinical utility of telomerase in cancerOncogene, 2002
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- Advanced ovarian cancerCurrent Treatment Options in Oncology, 2000
- The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoterHuman Molecular Genetics, 1999
- In vitro expression of the diphtheria toxin A-chain gene under the control of human chorionic gonadotropin gene promoters as a means of directing toxicity to ovarian cancer cell linesAmerican Journal of Obstetrics and Gynecology, 1997